{"success":true,"data":{"pressRelease":{"id":"20891","rtpr_id":"nBwZNrvva","ticker":"TWST","exchange":"NASDAQ","all_tickers":["TWST"],"title":"Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)","author":"Business Wire","published_at":"2026-05-05T12:00:01.228Z","article_body":"Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing\nRule 5635(c)(4)\n\nAs required by the rules of the Nasdaq Stock Market, Twist Bioscience\nCorporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap\ngrowth and value biotech company, today announced that a total of 115,279\nequity awards, consisting of 101,931 restricted stock units (“RSUs”) and\nup to 13,348 performance stock units (“PSUs”), will be granted to 53\nrecently hired individuals, in each case as an inducement material to their\nacceptance of employment with Twist. The employment inducement awards will be\ngranted under Twist’s Amended and Restated Inducement Equity Incentive Plan\nand related form of restricted stock unit award agreement in accordance with\nNasdaq Listing Rule 5635(c)(4).\n\nThe inducement plan is used exclusively for the grant of equity awards to\nindividuals who were not previously employees of Twist, or following a bona\nfide period of non-employment, as an inducement material to such individuals\nentering into employment with Twist, pursuant to Nasdaq Listing Rule\n5635(c)(4).\n\nA portion of the 101,931 RSUs vest over a 48-month period for each employee as\nfollows: 25% vests on the one-year anniversary of the applicable vesting\ncommencement date (the “Vesting Commencement Date”), and 1/16 of the RSUs\nvest on each quarterly anniversary (or the last day of the month if no such\nday exists) of the Vesting Commencement Date thereafter, subject to the\nemployee’s continued service through each vesting date. A portion of the\n101,931 RSUs vest over a 48-month period for each employee as follows: 1/16 of\nthe RSUs vest on each quarterly anniversary (or the last day of the month if\nno such day exists) of the Vesting Commencement Date, subject to the\nemployee’s continued service through each vesting date.\n\nUp to 13,348 PSUs vest on achievement of certain performance metrics set by\nthe Compensation Committee of the Company’s Board of Directors, to be\nachieved by no later than the end of the 2027 fiscal year (which can be earned\nat 50%-150% of 100% target), subject, in each case, to the employee’s\ncontinued service through the applicable vesting dates.\n\nAbout Twist Bioscience Corporation\n\nAt Twist Bioscience, our customizable solutions across the biological\ncontinuum raise the bar in diagnostics, therapeutics, industrial, agriculture\nand research markets.\n\nWe drive innovation with confidence, without compromise. Whether delivering\noligos, genes, proteins, libraries, characterization data, antibody discovery\nsolutions, or NGS workflow tools, our scientific expertise and exceptional\ncustomer experience help navigate complex challenges, all with precision and\nat the scale and speed customers require. By enhancing R&D efficiency at\nevery turn, we give scientists more shots on goal – more experiments, more\niterations, more chances for remarkable discoveries.\n\nTogether, we stand with customers in the relentless pursuit of progress,\nbacked by enterprise reliability, to shape a healthier and more sustainable\nfuture for all. For more information about our products and services, please\nvisit www.twistbioscience.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.twistbioscience.com&esheet=54528348&newsitemid=20260505506054&lan=en-US&anchor=www.twistbioscience.com&index=1&md5=59fb9522b464c17700a4a3d6b700ae46)\n.\n\nFollow us on LinkedIn\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Ftwist-bioscience%2F&esheet=54528348&newsitemid=20260505506054&lan=en-US&anchor=LinkedIn&index=2&md5=e7eda341efb493844dd70984422cfd9a)\n| X\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftwitter.com%2Ftwistbioscience&esheet=54528348&newsitemid=20260505506054&lan=en-US&anchor=X&index=3&md5=1edaaf972e31e2f8ae37c53dd242fd82)\n| YouTube\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.youtube.com%2Fc%2FTwistBioscience&esheet=54528348&newsitemid=20260505506054&lan=en-US&anchor=YouTube&index=4&md5=fad9c91ff73045449ba9d39bad095dd0)\n| Instagram\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.instagram.com%2Ftwist_bioscience%2F%3Fhl%3Den&esheet=54528348&newsitemid=20260505506054&lan=en-US&anchor=Instagram&index=5&md5=c38f8edf69034e25daa770bb495c5812)\n| Bluesky\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbsky.app%2Fprofile%2Ftwistbioscience.com&esheet=54528348&newsitemid=20260505506054&lan=en-US&anchor=Bluesky&index=6&md5=3a272bf594ac24013f387497aec88122)\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260505506054/en/\n(https://www.businesswire.com/news/home/20260505506054/en/)\n\nFor Investors: \n\nAngela Bitting\n\nSVP, Corporate Affairs\n\n925-202-6211\n\nabitting@twistbioscience.com (mailto:abitting@twistbioscience.com)\n\nFor Media: \n\nAmanda Houlihan\n\nCommunications Manager\n\n774-265-5334\n\nahoulihan@twistbioscience.com (mailto:ahoulihan@twistbioscience.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBwZNrvva","title":"Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)","author":"Business Wire","ticker":"TWST","created":"2026-05-05T12:00:01.228Z","tickers":["TWST"],"exchange":"NASDAQ","article_body":"Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing\nRule 5635(c)(4)\n\nAs required by the rules of the Nasdaq Stock Market, Twist Bioscience\nCorporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap\ngrowth and value biotech company, today announced that a total of 115,279\nequity awards, consisting of 101,931 restricted stock units (“RSUs”) and\nup to 13,348 performance stock units (“PSUs”), will be granted to 53\nrecently hired individuals, in each case as an inducement material to their\nacceptance of employment with Twist. The employment inducement awards will be\ngranted under Twist’s Amended and Restated Inducement Equity Incentive Plan\nand related form of restricted stock unit award agreement in accordance with\nNasdaq Listing Rule 5635(c)(4).\n\nThe inducement plan is used exclusively for the grant of equity awards to\nindividuals who were not previously employees of Twist, or following a bona\nfide period of non-employment, as an inducement material to such individuals\nentering into employment with Twist, pursuant to Nasdaq Listing Rule\n5635(c)(4).\n\nA portion of the 101,931 RSUs vest over a 48-month period for each employee as\nfollows: 25% vests on the one-year anniversary of the applicable vesting\ncommencement date (the “Vesting Commencement Date”), and 1/16 of the RSUs\nvest on each quarterly anniversary (or the last day of the month if no such\nday exists) of the Vesting Commencement Date thereafter, subject to the\nemployee’s continued service through each vesting date. A portion of the\n101,931 RSUs vest over a 48-month period for each employee as follows: 1/16 of\nthe RSUs vest on each quarterly anniversary (or the last day of the month if\nno such day exists) of the Vesting Commencement Date, subject to the\nemployee’s continued service through each vesting date.\n\nUp to 13,348 PSUs vest on achievement of certain performance metrics set by\nthe Compensation Committee of the Company’s Board of Directors, to be\nachieved by no later than the end of the 2027 fiscal year (which can be earned\nat 50%-150% of 100% target), subject, in each case, to the employee’s\ncontinued service through the applicable vesting dates.\n\nAbout Twist Bioscience Corporation\n\nAt Twist Bioscience, our customizable solutions across the biological\ncontinuum raise the bar in diagnostics, therapeutics, industrial, agriculture\nand research markets.\n\nWe drive innovation with confidence, without compromise. Whether delivering\noligos, genes, proteins, libraries, characterization data, antibody discovery\nsolutions, or NGS workflow tools, our scientific expertise and exceptional\ncustomer experience help navigate complex challenges, all with precision and\nat the scale and speed customers require. By enhancing R&D efficiency at\nevery turn, we give scientists more shots on goal – more experiments, more\niterations, more chances for remarkable discoveries.\n\nTogether, we stand with customers in the relentless pursuit of progress,\nbacked by enterprise reliability, to shape a healthier and more sustainable\nfuture for all. For more information about our products and services, please\nvisit www.twistbioscience.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.twistbioscience.com&esheet=54528348&newsitemid=20260505506054&lan=en-US&anchor=www.twistbioscience.com&index=1&md5=59fb9522b464c17700a4a3d6b700ae46)\n.\n\nFollow us on LinkedIn\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Ftwist-bioscience%2F&esheet=54528348&newsitemid=20260505506054&lan=en-US&anchor=LinkedIn&index=2&md5=e7eda341efb493844dd70984422cfd9a)\n| X\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftwitter.com%2Ftwistbioscience&esheet=54528348&newsitemid=20260505506054&lan=en-US&anchor=X&index=3&md5=1edaaf972e31e2f8ae37c53dd242fd82)\n| YouTube\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.youtube.com%2Fc%2FTwistBioscience&esheet=54528348&newsitemid=20260505506054&lan=en-US&anchor=YouTube&index=4&md5=fad9c91ff73045449ba9d39bad095dd0)\n| Instagram\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.instagram.com%2Ftwist_bioscience%2F%3Fhl%3Den&esheet=54528348&newsitemid=20260505506054&lan=en-US&anchor=Instagram&index=5&md5=c38f8edf69034e25daa770bb495c5812)\n| Bluesky\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbsky.app%2Fprofile%2Ftwistbioscience.com&esheet=54528348&newsitemid=20260505506054&lan=en-US&anchor=Bluesky&index=6&md5=3a272bf594ac24013f387497aec88122)\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260505506054/en/\n(https://www.businesswire.com/news/home/20260505506054/en/)\n\nFor Investors: \n\nAngela Bitting\n\nSVP, Corporate Affairs\n\n925-202-6211\n\nabitting@twistbioscience.com (mailto:abitting@twistbioscience.com)\n\nFor Media: \n\nAmanda Houlihan\n\nCommunications Manager\n\n774-265-5334\n\nahoulihan@twistbioscience.com (mailto:ahoulihan@twistbioscience.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-05-05T12:00:01.275967564Z","server_sent_at_ms":1777982401275},"received_at":"2026-05-05T12:00:01.668Z","source_url":"https://www.businesswire.com/news/home/20260505506054/en/"},"analysis":{"id":"17464","press_release_id":"20891","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Twist Bioscience granted 115,279 equity awards to 53 new employees as an employment inducement under NASDAQ Listing Rule 5635(c)(4).\n\nThe awards consist of 101,931 restricted stock units and up to 13,348 performance stock units, generally vesting over 48 months.\n\nThis is a routine administrative disclosure required by Nasdaq and does not alter the company's financial outlook.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine corporate governance filing; no material impact."},"keyFigures":{"customDimensions":{"new_hires":53,"psus_granted":13348,"rsus_granted":101931,"total_awards":115279}},"quotedText":"","namedEntities":{"people":[{"name":"Angela Bitting","role":"SVP, Corporate Affairs"},{"name":"Amanda Houlihan","role":"Communications Manager"}],"products":[],"companies":[{"name":"Twist Bioscience Corporation","ticker":"TWST"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine disclosure of inducement grants for new hires required by Nasdaq rules. No impact on financials, strategy, or operations."},"tickerRelevance":{"others":[],"primary":"TWST"},"globalImportance":10,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"routine_compensation_disclosure","sectorWeight":"biotech"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Twist Bioscience granted 115,279 equity awards to 53 new employees as an employment inducement under NASDAQ Listing Rule 5635(c)(4).\n\nThe awards consist of 101,931 restricted stock units and up to 13,348 performance stock units, generally vesting over 48 months.\n\nThis is a routine administrative disclosure required by Nasdaq and does not alter the company's financial outlook.","key_figures":{"customDimensions":{"new_hires":53,"psus_granted":13348,"rsus_granted":101931,"total_awards":115279}},"named_entities":{"people":[{"name":"Angela Bitting","role":"SVP, Corporate Affairs"},{"name":"Amanda Houlihan","role":"Communications Manager"}],"products":[],"companies":[{"name":"Twist Bioscience Corporation","ticker":"TWST"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:6c7fa2f5e3b62e83","schema_hash":"sha256:ee8f711bc9bfba0d","created_at":"2026-05-06T18:22:50.648Z","global_importance":10,"audience_relevance":15,"importance_components":{"tickerTier":"mid-cap","eventGravity":"routine_compensation_disclosure","sectorWeight":"biotech"}},"durationMs":null,"modelName":"glm-4.7"}}